reports
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Thomas Couvreur
- Jacob Mekhael
MaaT Pharma Business update highlights upcoming priorities, final ARES...
MaaT provides a business update, which reiterated the company's progress with respect to its pipeline, and following the previously announced EU regulatory submission for MaaT013 in aGvHD, the company continues to search for a commercialisation partner in Europe ahead of a potential approval in 2H26. Timeline for MaaT013 US trial launch shifts to 2026 (from 4Q25) to focus resources on the European opportunity. Looking ahead, data updates for MaaT013 in aGvHD (final results incl. 12-month OS), as...
- Jacob Mekhael
MaaT Pharma Updated MaaT013 aGvHD EAP data at EHA shows consistent out...
MaaT reported updated early access program (EAP) results for MaaT013 (microbiome therapy, enema formulation) in aGvHD at EHA, being held 12-15 June. The data, which was previously shared in the abstract last month, shows that the response rates and overall survival observed in the steroid refractory and ruxulitinib resistant subset of patients (n=70) are in line with what was observed in the phase 3 ARES trial. In our view, this points to the consistency of outcomes with MaaT013 in this patient ...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Michiel Declercq
- Thomas Vranken
- Wim Lewi
GTT : Descriptif du programme de rachat d'actions
GTT : Descriptif du programme de rachat d'actions GAZTRANSPORT ET TECHNIGAZSociété anonyme au capital de 371 177,72 eurosSiège social : 1 route de Versailles – 78470 Saint-Rémy-lès-Chevreuse662 001 403 R.C.S. Versailles Descriptif du programme de rachat d'actions établi conformément aux dispositions des articles 241-1 et suivants du Règlement général de l'Autorité des marchés financiers Mise en œuvre du programme de rachat d'actions autorisé par l'assemblée générale mixte des actionnaires en date du 11 juin 2025 Emetteur : GTT / code ISIN FR 0011726835 (compartiment A) Titres concernés ...
GTT: Main terms and conditions of the share buy-back programme
GTT: Main terms and conditions of the share buy-back programme GAZTRANSPORT ET TECHNIGAZSociété anonyme with a share capital of €371,177.72Registered office: 1 route de Versailles – 78470 Saint-Rémy-lès-Chevreuse, France662 001 403 R.C.S. Versailles Main terms and conditions of the share buy-back programme in accordance with the conditions and obligations set by Articles 241-1 and seq. of the General Regulations of the Autorité des marchés financiers (AMF) Implementation of the share buy-back programme authorised by the Combined Shareholders’ meeting on June 11, 2025 Issuer: GTT / ISIN ...
GTT’s 2025 combined shareholders’ Annual General Meeting summary
GTT’s 2025 combined shareholders’ Annual General Meeting summary GTT’s 2025 combined shareholders’ Annual General Meeting summary Saint-Rémy-lès-Chevreuse – June 12, 2025. The combined shareholders’ Annual General Meeting (AGM) of GTT (Gaztransport et Technigaz) met yesterday, under the chairmanship of Philippe Berterottière, Chairman and CEO of GTT. Shareholders were not only able to attend the meeting in person, but also to follow it via a live video webcast on the company's website: . A replay of the meeting is available at the same address. All resolutions submitted to the Annual G...
GTT - Compte rendu de l’Assemblée générale mixte des actionnaires 2025
GTT - Compte rendu de l’Assemblée générale mixte des actionnaires 2025 Compte rendu de l’Assemblée générale mixte des actionnaires 2025 Saint-Rémy-lès-Chevreuse – Le 12 juin 2025. L’Assemblée générale mixte des actionnaires de GTT (Gaztransport et Technigaz) s’est réunie hier sous la présidence de Philippe Berterottière, Président-Directeur général. Les actionnaires ont pu assister physiquement à l’Assemblée générale mais également la suivre via une retransmission vidéo en direct sur le site internet de la société : . La rediffusion de l’assemblée est disponible, à cette même adresse. T...
GTT: Monthly disclosure of the total number of voting rights and share...
GTT: Monthly disclosure of the total number of voting rights and shares composing the share capital Monthly disclosure of the total number of voting rights and shares composing the share capital Articles L. 233-8-II of the French Commercial Code and 223-16 of the General Regulation of the Autorité des Marchés Financiers Saint-Rémy-lès-Chevreuse, June 9, 2025 Date Total number of shares Theoretical total number of voting rights1 Net total number of voting rights2 May 31, 2025 37,117,772 37,117,772 37,030,337 Investor Relations Contact / 87 1 C...
GTT : Information mensuelle relative au nombre total de droits de vote...
GTT : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Articles L. 233-8-II du Code de commerce et 223-16 du Règlement général de l’Autorité des marchés financiers Saint-Rémy-lès-Chevreuse, le 9 juin 2025 Date Nombre total d’actions composant le capital Nombre total de droits de vote théoriques1 Nombre total de droits de vote nets2 31 mai 2025 37 117 772 37 117 772 37 030 337 Contact Relations Investisseurs : / 87 ...
- Jacob Mekhael
MaaT Pharma Completes EU regulatory submission for MaaT013 in aGvHD
MaaT announced the submission of the Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its lead drug candidate MaaT013 (microbiome therapy, enema formulation) in aGvHD under the brand name Xervyteg. Potential approval could be granted in 2H26, and MaaT is actively exploring strategic partnerships to commercialise MaaT013 in Europe. We believe the solid phase 3 results and good uptake in the early access program will be supportive of MaaT013's commercial launch ...
- Guy Sips
- Jacob Mekhael
- Lynn Hautekeete
- Michiel Declercq
- Julian Dobrovolschi
- Marc Lavaud
- Nicolas Thorez
- Youssef Besbes
- Julian Dobrovolschi
- Marc Lavaud
- Nicolas Thorez
- Youssef Besbes
- Gautier Le Bihan
- Gautier Le Bihan
GTT : Notice regarding availability of explanatory documentation relat...
GTT : Notice regarding availability of explanatory documentation related to the combined shareholders' meeting to be held on June 11, 2025 Terms of availability of preparatory documents for the combined general meeting of shareholders on June 11, 2025 Saint-Rémy-lès-Chevreuse – May 20, 2025. GTT (Gaztransport et Technigaz) informs its shareholders that the combined (ordinary and extraordinary) general meeting of shareholders will be held on Wednesday June 11, 2025 at 3:00 pm. The notice of meeting, including the agenda and the draft resolutions as well as the conditions and modalities of ...
GTT : Modalités de mise à disposition des documents préparatoires à l'...
GTT : Modalités de mise à disposition des documents préparatoires à l'assemblée générale mixte des actionnaires du 11 juin 2025 Modalités de mise à disposition des documents préparatoires à l’assemblée générale mixte des actionnaires du 11 juin 2025 Saint-Rémy-lès-Chevreuse – Le 20 mai 2025. GTT (Gaztransport et Technigaz) informe ses actionnaires que l’assemblée générale mixte (ordinaire et extraordinaire) des actionnaires se tiendra le mercredi 11 juin 2025 à 15 heures. L’avis de réunion, comportant l’ordre du jour et les projets de résolutions ainsi que les conditions et modalités de p...
- Jacob Mekhael
EHA abstracts Autolus, Galapagos, MaaT
The abstracts for presentations at EHA (12-15 June) became available yesterday during the day (here). While we may have to wait until the actual conference for the latest datasets, here in this note are some key takeaways for our coverage including updates from Autolus (long-term findings and predictors of sustained remission for Aucatzyl in r/r adult ALL, as well as age stratified outcomes), Galapagos (more data and follow up from its decentralised CAR-T program) and MaaT (additional data from ...
- Guy Sips
- Jacob Mekhael
- Lynn Hautekeete
- Michiel Declercq
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.